Entering text into the input field will update the search result below

An FDA advisory committee votes 9- 2, with one abstention, to approve the anticoagulant drug...

Sep. 08, 2011 5:19 PM ETJohnson & Johnson (JNJ) StockJNJ, BAYRYBy: David Yelle, SA News Editor

An FDA advisory committee votes 9- 2, with one abstention, to approve the anticoagulant drug Xarelto manufactured jointly by Johnson & Johnson (NYSE:JNJ) and Bayer AG (OTCPK:BAYRY). JNJ +0.6%, OTCPK:BAYRY -0.1% AH.

Recommended For You

More Trending News

About JNJ Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
JNJ--
Johnson & Johnson